Table 2

 Baseline and postreatment variables of patients with final low (<4.0 mmol/l) or high (⩾4.0 mmol/l) lactate levels*

VariableLow (n = 14)High (n = 4)pMean difference (95%CI)
*Data are presented as mean (1 SD).
Baseline
Duration of attack prior to ED presentation, h71.7 (32.6)15.5 (1.3)0.0156.2 (18.1 to 94.2)
Respiratory rate, breaths/min20.5 (3.1)21.4 (2.0)0.5−0.9 (−4.4 to 2.6)
Heart rate, beats/min92.3 (3.9)102.5 (1.3)0.005−10.2 (−14.4 to −5.9)
FEV1,% of predicted34.8 (11.1)23.0 (1.2)0.211.8 (−0.2 to 23.8)
SpO2,%96.4 (1.5)93.2 (2.6)0.033.2 (1.1 to 5.3)
pH7.4 (0.0)7.3 (0.0)0.080.0 (−0.0 to 0.0)
pO2, mm Hg80.8 (8.6)61.6 (8.9)0.00919.2 (8.7 to 29.6)
pCO2, mm Hg34.8 (2.9)39.8 (1.0)0.01−5.0 (−8.2 to −1.7)
HCO3, mmol/l22.3 (1.4)23.3 (0.5)0.2−1.0 (−2.5 to 0.5)
Na, mmol/l138.9 (2.7)137.2 (0.5)0.21.7 (−1.2 to 4.6)
K, mmol/l3.9 (0.2)3.4 (0.2)0.0050.4 (0.3 to 0.6)
Cl, mmol/l102.0 (3.3)100.5 (1.0)0.31.5 (−2.0 to 5.0)
Lactate, mmol/l1.1 (0.5)1.3 (0.2)0.4−0.2 (−0.7 to 0.3)
Final (120 min)
Respiratory rate, breaths/min20.6 (3.2)21.2 (2.3)0.6−0.6 (−4.2 to 3.0)
Heart rate, beats/min99.0 (8.7)109.0 (2.1)0.04−10.0 (−19.4 to −0.5)
FEV1,% of predicted70.9 (23.0)73.0 (22.6)0.7−2.1 (−29.6 to 25.4)
SpO2,%97.2 (1.5)98.0 (1.4)0.3−0.8 (−2.5 to 0.9)
pH7.4 (0.0)7.3 (0.0)0.20.0 (−0.0 to 0.0)
pO2, mm Hg82.8 (10.2)82.3 (10.9)0.60.5 (−11.9 to 12.9)
pCO2, mm Hg37.0 (3.5)38.7 (0.8)0.2−1.7 (−5.5 to 2.1)
HCO3, mmol/l22.6 (0.9)21.9 (1.2)0.20.7 (−0.4 to 1.8)
Na, mmol/l142.9 (7.1)140.0 (1.4)0.22.9 (−5.6 to 11.4)
K, mmol/l3.8 (0.5)3.2 (0.1)0.010.5 (0.0 to 1.0)
Cl, mmol/l105.2 (7.6)102.2 (0.9)0.23.0 (−5.2 to 11.2)
Lactate, mmol/l2.0 (0.7)6.6 (1.5)0.003−4.6 (−5.7 to −3.5)